Samsung Electronics confirmed that their medical equipment unit “Samsung Medison” has officially  acquired the French AI MedTech startup, SONIO for $92 Million. Today this morning the company  confirmed that they want to work with Sonio to expand the AI-powered healthcare solution business.  Through this investment, Samsung Medison is said to be gaining access to AI development in Europe,  which will enhance its medical AI solutions with Sonio’s AI diagnostic assistant and reporting  technology.  

Samsung Medison is a medical device company specializing in diagnostic imaging devices. As of May  8, the company Samsung Medison is said to have entered into a share purchase agreement to acquire  this MedTech startup, Sonio. According to Yonhap news agency, this startup aims for AI development  in the medical field, AI development for diagnostic reporting in obstetrics and gynaecology ultrasounds to be precise.  

Sonio is a Paris-based startup and has developed various AI-powered solutions in the last few months.  This MedTech startup also won approval from the U.S. Food and Drug Administration (FDA) last year  for its AI-powered software solution, designed to identify prenatal syndromes and abnormalities  through ultrasound. 

Samsung is already known for its built-in integration with the best healthcare solutions. To provide  best-in-class healthcare, homecare, and remote monitoring the company has been continuously working with industry-leading healthcare software providers. The company has been working in Digital  Health solutions for years, so the addition of Sonio raised expectations of everyone to see how  Samsung will work with this French AI MedTech startup.  

Medison said it is acquiring Sonio, the AI software company for $92.4 Million, which is about  126 billion won. Everyone is excited to see how these two will work together, as this can be seen as an  opportunity for South Korea’s Samsung Medison to get a grip on France’s AI market using this MedTech startup. Through this acquisition, Samsung Medison can access the AI development talent in Europe 

and enhance its Medical AI solutions with Sonio’s assistant and technologies. Samsung is seeing this  as a step to expand its AI-powered healthcare solutions to Europe. As Samsung Electronics owns a  68.5% stake, which is more than half the stake in Samsung Medison, they are just as invested to see  what steps the company will take in the Field of AI healthcare. 

Conclusion: 

Samsung Medison bought a French MedTech startup called Sonio for $92.4 million. SONIO focuses on smart healthcare technology using artificial intelligence (AI). Samsung Medison acquired this startup  to work with Sonio and make best-in-class medical and healthcare solutions. They believe working with  Sonio will help them have advancements in AI healthcare solutions, benefiting healthcare providers. 

With Samsung Medison’s commitment to expanding its AI-powered healthcare solutions, this  partnership promises to advance diagnostic imaging and reporting technologies. Samsung Medison  aims to enhance its offerings and solidify its position in the global healthcare market with Sonio’s  expertise in AI development and its FDA-approved software solutions. With Samsung Electronics’ big  stake in Samsung Medison, there is strong backing for this strategic move.